Description
AtracuriumisareversIBLeinhibitorofacetylcholinereceptors(AChRs)thatactsasanon-depolarizingneuromuscularjunctionblocker(NMJ);itcausesmuscularparalysisandisclinicallyusedasananesthetic.
AtracuriumisareversIBLeinhibitorofacetylcholinereceptors(AChRs)thatactsasanon-depolarizingneuromuscularjunctionblocker(NMJ);itcausesmuscularparalysisandisclinicallyusedasananesthetic.
CasNo. | 64228-81-5 |
---|---|
Purity | ≥95% |
Formula | C53H72N2O12•(C6H5O3S)2 |
FormulaWt. | 1243.49 |
ChemicalName | 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoyl-oxy]pentyl-3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoate |
IUPACName | benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate |
Synonym | BW-33A;Tracrium |
MeltingPoint | 185-194°C |
Solubility | Solubleinwater(27mg/mL).SolubleinDMSO(>100mg/mL). |
Appearance | White/yellowcrystallinepowder |
StoreTemp | 4°C |
---|---|
ShipTemp | Ambient |
MSDS | A7668MSDSPDF |
---|---|
InfoSheet | A7668InfoSheetPDF |
ShashankD,SinghNR,SinghLK.Effectsofpretreatmentwithdifferentneuromuscularblockingagentsonfacilitationofintubationwithrocuronium:AProspectiverandomizedcomparativestudy.IndianJAnaesth.2014May;58(3):303-8.PMID:25024474.
JonssonM,GurleyD,DabrowskiM,etal.Distinctpharmacologicpropertiesofneuromuscularblockingagentsonhumanneuronalnicotinicacetylcholinereceptors:apossibleexplanationforthetrain-of-fourfade.Anesthesiology.2006Sep;105(3):521-33.PMID:16931985.
BowmanWC.Neuromuscularblock.BrJPharmacol.2006Jan;147Suppl1:S277-86.PMID:16402115.